<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40747850</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-2156</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>Brain : a journal of neurology</Title><ISOAbbreviation>Brain</ISOAbbreviation></Journal><ArticleTitle>Alzheimer and cardiovascular genetic scores and cognition: the FINGER randomized controlled trial.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">awaf277</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awaf277</ELocationID><Abstract><AbstractText>Alzheimer's disease and coronary artery disease are common late-life chronic conditions and share multiple risk factors, including Apolipoprotein E (APOE) &#x3b5;4 allele. A meta-analysis of two multidomain lifestyle intervention trials indicated more cognitive benefit in APOE4 carriers compared with non-carriers. This study investigated the impact of genetic risk scores for Alzheimer's disease and coronary artery disease (AD-GRS, CAD-GRS) on cognition in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) randomized controlled trial. FINGER included 1259 at-risk individuals without dementia from the general population, aged 60-77 years. Participants were randomized 1:1 to 2-year multidomain lifestyle intervention or regular health advice. Primary outcome was change in cognition based on a modified Neuropsychological Test Battery (14 tests). Previous comprehensive AD-GRS and CAD-GRS were calculated using GWAS data (1,177 participants with 585 in control and 592 in intervention group, exploratory analysis). The intervention-control difference in annual overall cognition change (95% CI) for participants with AD-GRS above/below the median (i.e., higher/lower risk) was 0&#xb7;032 (0&#xb7;002-0&#xb7;063) versus 0&#xb7;017 (-0&#xb7;011- 0&#xb7;045), and for CAD-GRS above/below the median was 0&#xb7;031 (0&#xb7;002-0&#xb7;059) versus 0&#xb7;016 (-0&#xb7;012-0&#xb7;044). AD-GRS or CAD-GRS were not significantly related to the intervention effect overall (p&gt;0&#xb7;46), but for AD-GRS there were differences between women and men (p=0&#xb7;024). The intervention-control difference in annual overall score change was 0&#xb7;045 (0&#xb7;004-0&#xb7;087) for higher-risk women, 0&#xb7;003 (-0&#xb7;040-0&#xb7;047) for lower-risk women, 0&#xb7;019 (-0&#xb7;026-0&#xb7;064) for higher-risk men, and 0&#xb7;027 (-0&#xb7;009-0&#xb7;064) for lower-risk men. People with genetic susceptibility for Alzheimer's disease/dementia or coronary artery disease can benefit from multidomain lifestyle interventions. Although the findings for AD-GRS and CAD-GRS risk groups were similar to APOE4 carrier status, with additional gender differences for AD-GRS, these exploratory findings need to be verified across several multidomain lifestyle trials to ensure adequate statistical power and inclusion of genetically diverse populations.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2025. Published by Oxford University Press on behalf of the Guarantors of Brain.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Saadmaan</LastName><ForeName>Gazi</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-0925-7609</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, 70210 Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalmasso</LastName><ForeName>Maria Carolina</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Studies in Neuroscience and Complex Systems Unit (ENyS-CONICET-HEC-2 UNAJ), B1888AAE Florencio Varela, Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neurogenetics and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, University of Cologne, Medical Faculty, 50923 Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maria</LastName><ForeName>Maleeha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70210 Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehtisalo</LastName><ForeName>Jenni</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-8818-0848</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, 70210 Kuopio, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public Health, Finnish Institute for Health and Welfare, 00300 Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hiltunen</LastName><ForeName>Mikko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Biomedicine, University of Eastern Finland, 70210 Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaikkonen</LastName><ForeName>Minna U</ForeName><Initials>MU</Initials><Identifier Source="ORCID">0000-0001-6294-0979</Identifier><AffiliationInfo><Affiliation>A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70210 Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lev&#xe4;lahti</LastName><ForeName>Esko</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Public Health, Finnish Institute for Health and Welfare, 00300 Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mangialasche</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 171 76 Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Unit Aging, Theme Inflammation and Aging, Karolinska University Hospital, 171 76 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perola</LastName><ForeName>Markus</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4842-1667</Identifier><AffiliationInfo><Affiliation>Department of Public Health, Finnish Institute for Health and Welfare, 00300 Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramirez</LastName><ForeName>Alfredo</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4991-763X</Identifier><AffiliationInfo><Affiliation>Division of Neurogenetics and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, University of Cologne, Medical Faculty, 50923 Cologne, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Old Age Psychiatry and Cognitive Disorders, University Hospital Bonn, University of Bonn, 53127 Bonn, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE Bonn), 53127 Bonn, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Glenn Biggs Institute for Alzheimer's &amp; Neurodegenerative Diseases, University of Texas Health Sciences Center, San Antonio, TX 78229, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Disease (CECAD), University of Cologne, 50923 Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stephen</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, 70210 Kuopio, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 171 76 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngandu</LastName><ForeName>Tiia</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-3698-2021</Identifier><AffiliationInfo><Affiliation>Department of Public Health, Finnish Institute for Health and Welfare, 00300 Helsinki, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 171 76 Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Public Health and Clinical Nutrition, University of Eastern Finland, 70210 Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kivipelto</LastName><ForeName>Miia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 171 76 Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Unit Aging, Theme Inflammation and Aging, Karolinska University Hospital, 171 76 Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Public Health and Clinical Nutrition, University of Eastern Finland, 70210 Kuopio, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ageing Epidemiology Research Unit, School of Public Health, Imperial College London, W6 8RP London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stockholm Sjukhem, 112 19 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solomon</LastName><ForeName>Alina</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, 70210 Kuopio, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 171 76 Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ageing Epidemiology Research Unit, School of Public Health, Imperial College London, W6 8RP London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Brain</MedlineTA><NlmUniqueID>0372537</NlmUniqueID><ISSNLinking>0006-8950</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">cognition</Keyword><Keyword MajorTopicYN="N">genetic risk scores</Keyword><Keyword MajorTopicYN="N">multidomain intervention</Keyword><Keyword MajorTopicYN="N">randomized controlled trial</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>1</Day><Hour>12</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>1</Day><Hour>12</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>1</Day><Hour>7</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40747850</ArticleId><ArticleId IdType="doi">10.1093/brain/awaf277</ArticleId><ArticleId IdType="pii">8220705</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>